Trial intelligence / Profile preview

IV ferric carboxymaltose vs oral iron for preoperative anemia in colorectal cancer surgery

2014-002827-87Phase 4Active

Sponsor
Academic Medical Center
Start
Oct 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ferric carboxymaltose in colorectal cancer (CRC) and anaemia (2 arms), sponsored by Academic Medical Center. Primary endpoint: Hemoglobin normalization rate. Started Oct 2014; status: active.

02

Drugs

ferric carboxymaltose
03

Conditions

colorectal cancer (CRC)anaemia

Beyond the preview

Go deeper on 2014-002827-87.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-002827-87.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call